221 related articles for article (PubMed ID: 15273263)
1. Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users.
Friedman SR; Tempalski B; Cooper H; Perlis T; Keem M; Friedman R; Flom PL
J Urban Health; 2004 Sep; 81(3):377-400. PubMed ID: 15273263
[TBL] [Abstract][Full Text] [Related]
2. HIV among injection drug users in large US metropolitan areas, 1998.
Friedman SR; Lieb S; Tempalski B; Cooper H; Keem M; Friedman R; Flom PL
J Urban Health; 2005 Sep; 82(3):434-45. PubMed ID: 16014877
[TBL] [Abstract][Full Text] [Related]
3. Estimating the prevalence of injection drug users in the U.S. and in large U.S. metropolitan areas from 1992 to 2002.
Brady JE; Friedman SR; Cooper HL; Flom PL; Tempalski B; Gostnell K
J Urban Health; 2008 May; 85(3):323-51. PubMed ID: 18344002
[TBL] [Abstract][Full Text] [Related]
4. Estimates of the population prevalence of injection drug users among hispanic residents of large US metropolitan areas.
Pouget ER; Friedman SR; Cleland CM; Tempalski B; Cooper HL
J Urban Health; 2012 Jun; 89(3):527-64. PubMed ID: 22411420
[TBL] [Abstract][Full Text] [Related]
5. HIV prevalence rates among injection drug users in 96 large US metropolitan areas, 1992-2002.
Tempalski B; Lieb S; Cleland CM; Cooper H; Brady JE; Friedman SR
J Urban Health; 2009 Jan; 86(1):132-54. PubMed ID: 19015995
[TBL] [Abstract][Full Text] [Related]
6. Estimating the prevalence of injection drug use among black and white adults in large U.S. metropolitan areas over time (1992--2002): estimation methods and prevalence trends.
Cooper HL; Brady JE; Friedman SR; Tempalski B; Gostnell K; Flom PL
J Urban Health; 2008 Nov; 85(6):826-56. PubMed ID: 18709555
[TBL] [Abstract][Full Text] [Related]
7. Predictors of the degree of drug treatment coverage for injection drug users in 94 metropolitan areas in the United States of America.
Friedman SR; Tempalski B; Brady JE; Friedman JJ; Cooper HL; Flom PL; McGrath MM; Gostnell K; Des Jarlais DC
Int J Drug Policy; 2007 Dec; 18(6):475-85. PubMed ID: 18061873
[TBL] [Abstract][Full Text] [Related]
8. Changes in the prevalence of injection drug use among adolescents and young adults in large U.S. metropolitan areas.
Chatterjee S; Tempalski B; Pouget ER; Cooper HL; Cleland CM; Friedman SR
AIDS Behav; 2011 Oct; 15(7):1570-8. PubMed ID: 21739288
[TBL] [Abstract][Full Text] [Related]
9. Patterns of drug use and associated harms among rural injecting drug users: comparisons with metropolitan injecting drug users.
Day C; Conroy E; Lowe J; Page J; Dolan K
Aust J Rural Health; 2006 Jun; 14(3):120-5. PubMed ID: 16706881
[TBL] [Abstract][Full Text] [Related]
10. Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas.
Friedman SR; Cooper HL; Tempalski B; Keem M; Friedman R; Flom PL; Des Jarlais DC
AIDS; 2006 Jan; 20(1):93-9. PubMed ID: 16327324
[TBL] [Abstract][Full Text] [Related]
11. Metropolitan social environments and pre-HAART/HAART era changes in mortality rates (per 10,000 adult residents) among injection drug users living with AIDS.
Friedman SR; West BS; Pouget ER; Hall HI; Cantrell J; Tempalski B; Chatterjee S; Hu X; Cooper HL; Galea S; Des Jarlais DC
PLoS One; 2013; 8(2):e57201. PubMed ID: 23437341
[TBL] [Abstract][Full Text] [Related]
12. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with HIV testing among male injecting drug users: findings from a cross-sectional behavioural and biological survey in Manipur and Nagaland, India.
Ganju D; Ramesh S; Saggurti N
Harm Reduct J; 2016 Jun; 13(1):21. PubMed ID: 27324253
[TBL] [Abstract][Full Text] [Related]
14. Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug.
Tempalski B; Cooper HL; Friedman SR; Des Jarlais DC; Brady J; Gostnell K
Int J Drug Policy; 2008 Apr; 19 Suppl 1(Suppl 1):S47-58. PubMed ID: 18295468
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of markers for hepatitis B virus and HIV-1 among drug injectors in London: injecting careers, positivity and risk behaviour.
Rhodes T; Hunter GM; Stimson GV; Donoghoe MC; Noble A; Parry J; Chalmers C
Addiction; 1996 Oct; 91(10):1457-67. PubMed ID: 8917914
[TBL] [Abstract][Full Text] [Related]
16. Trends over time in HIV prevalence among people who inject drugs in 89 large US metropolitan statistical areas, 1992-2013.
Williams LD; Ibragimov U; Tempalski B; Stall R; Satcher Johnson A; Wang G; Cooper HLF; Friedman SR
Ann Epidemiol; 2020 May; 45():12-23. PubMed ID: 32439148
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the prevalence of HIV infection and injecting risk behaviour in urban and rural samples in Scotland.
Haw S; Higgins K
Addiction; 1998 Jun; 93(6):855-63. PubMed ID: 9744121
[TBL] [Abstract][Full Text] [Related]
18. Drug use among the urban poor in Kolkata: behaviour and environment correlates of low HIV infection.
Panda S; Saha U; Pahari S; Nathan M; Poddar S; Neogi D; Sarkar M; Pal NK; Mahalanabis D
Natl Med J India; 2002; 15(3):128-34. PubMed ID: 12186324
[TBL] [Abstract][Full Text] [Related]
19. Persistence of low drug treatment coverage for injection drug users in large US metropolitan areas.
Tempalski B; Cleland CM; Pouget ER; Chatterjee S; Friedman SR
Subst Abuse Treat Prev Policy; 2010 Sep; 5():23. PubMed ID: 20858258
[TBL] [Abstract][Full Text] [Related]
20. The role of "long-term" and "new" injectors in a declining HIV/AIDS epidemic in Rio de Janeiro, Brazil.
Hacker MA; Friedman SR; Telles PR; Teixeira SL; Bongertz V; Morgado MG; Bastos FI
Subst Use Misuse; 2005; 40(1):99-123. PubMed ID: 15702651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
